Scientists uncover strategy to effectively target drug resistant childhood cancers
Researchers used gene silencing to identify MST1R – a complimentary drug target for IGF1R therapy which, when silenced, boosts the efficacy of existing cancer …
Researchers used gene silencing to identify MST1R – a complimentary drug target for IGF1R therapy which, when silenced, boosts the efficacy of existing cancer …
October 14, 2010, Victoria, BC – The Kennametal Foundation announced a donation of $15,000 to the BC Cancer Foundation’s Inspire the World campaign. This …
As you might imagine, leading the BC Cancer Agency’s breast cancer research program keeps me very busy! And I’m not the only one: …
Researchers with the BC Cancer Agency’s Genome Sciences Centre developed two new approaches – ALEXASeq and Trans-ABySS – to characterize how the information in …
October 6, 2010, Victoria, B.C. - BC Cancer Foundation is pleased to announce a donation of $50,000 from League Assets Corp. to its Inspire …
We’ve been fortunate to have PET/CT imaging for patients with suspected or diagnosed cancer for the past five years. However, demand has been growing, …
Another part of my work is to lead an active research group on “Functional Cancer Imaging.” The purpose of my research is to improve …
I’m excited because yesterday we officially celebrated the opening of the cyclotron and the radiopharmaceutical facility at the BC Cancer Agency’s Centre of Excellence …
September 27, 2010, Vancouver, BC – The official opening of a new $15-million radiopharmaceutical facility brings the production of radiotracers used in PET/CT scans …
As you may have heard, yesterday we lost our dear friend Sindi Hawkins. Sindi was a champion, an ambassador and a leading light for the …